Back
Atlassian Corp. Vs. Nektar Therapeutics Industry Stock Comparison
Sell
50
TEAM
Atlassian Corp.
Last Price:
$161.04
Seasonality Move:
2.26%
Sell
46
NKTR
Nektar Therapeutics
Last Price:
$46.82
Seasonality Move:
6.44%
Sell
50
Atlassian Corp. (TEAM)
is a Sell
Is Atlassian Corp. a Buy, Sell or Hold?
-
The current Atlassian Corp. [TEAM] share price is $161.07. The Score for TEAM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
TEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Nektar Therapeutics (NKTR)
is a Sell
Is Nektar Therapeutics a Buy, Sell or Hold?
-
The current Nektar Therapeutics [NKTR] share price is $46.84. The Score for NKTR is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TEAM Stock Price Chart
What is Atlassian Corp.'s stock price today?
-
The Atlassian Corp. share price today is $161.07Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TEAM is experiencing selling pressure, which indicates risk of future bearish movement.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $46.84Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.
TEAM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 30.57 | Buy |
| Relative Strength Index (14 RSI): | 55.03 | Buy |
| Chaikin Money Flow: | -3409245 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (148.24 - 161.4) | Buy |
| Bollinger Bands (100): | (152.19 - 172.97) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.95 | Sell |
| Relative Strength Index (14 RSI): | 38.83 | Sell |
| Chaikin Money Flow: | 857593 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.69 - 61.39) | Sell |
| Bollinger Bands (100): | (34.99 - 62.73) | Sell |
TEAM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 161.73 | Sell |
| 20-day SMA: | 156.67 | Buy |
| 50-day SMA: | 157.08 | Buy |
| 200-day SMA: | 186.01 | Sell |
| 8-day EMA: | 86.09 | Buy |
| 20-day EMA: | 42.19 | Buy |
| 50-day EMA: | 18.4 | Buy |
| 200-day EMA: | 4.81 | Buy |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.29 | Sell |
| 20-day SMA: | 55.51 | Sell |
| 50-day SMA: | 57.37 | Sell |
| 200-day SMA: | 31.53 | Buy |
| 8-day EMA: | 49.58 | Sell |
| 20-day EMA: | 53.48 | Sell |
| 50-day EMA: | 54.29 | Sell |
| 200-day EMA: | 38.34 | Buy |
Atlassian Corp. Earnings Growth & TEAM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.69 per share, and an increase next year of $1.31 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.
Atlassian Corp. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||